Is Lexicon Pharmaceuticals Inc (LXRX) Stock at the Top of the Biotechnology Industry?

Lexicon Pharmaceuticals Inc (LXRX) is near the middle in its industry group according to InvestorsObserver. LXRX gets an overall rating of 45. That means it scores higher than 45 percent of stocks. Lexicon Pharmaceuticals Inc gets a 53 rank in the Biotechnology industry. Biotechnology is number 52 out of 148 industries.

LXRX has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on LXRX!

See Full LXRX Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Lexicon Pharmaceuticals Inc Stock Today?

Lexicon Pharmaceuticals Inc (LXRX) stock is down -8.21% while the S&P 500 has risen 0.38% as of 10:16 AM on Friday, Nov 10. LXRX is down -$0.08 from the previous closing price of $1.03 on volume of 674,477 shares. Over the past year the S&P 500 is higher by 10.30% while LXRX is down -57.59%. LXRX lost -$0.76 per share the over the last 12 months. Click Here to get the full Stock Report for Lexicon Pharmaceuticals Inc stock.